Vincent Ten Cate: The Largest Blood-Based EWAS of Atherosclerosis to Date
Vincent Ten Cate, Group Leader at the University Medical Center Mainz, shared a post on LinkedIn about a recent article he and his co-authord, published in JACC, adding:
“Excited to share our new publication in JACC Journals, presenting the largest blood-based epigenome-wide association study (EWAS) of atherosclerosis to date.
Analyzing 767,735 CpG sites in 3,688 participants from the Gutenberg Health Study and the MyoVasc study, we identified 1,687, 3,131, and 5,852 differentially methylated CpG sites associated with carotid, coronary, and peripheral atherosclerosis, respectively, with 2,155 sites shared across multiple vascular beds.
The strongest signals mapped to four loci: an intergenic region near ALPP/ALPG, AHRR, PRSS23, and F2RL3, with additional prominent associations in ABCG1 and DHCR24 for coronary atherosclerosis.
These genes point toward pathways involving smoking exposure, platelet reactivity and thrombosis, inflammation, and lipid metabolism.
While having been identified in relation to presence of atherosclerosis at baseline, methylation-based scores also predicted future major adverse cardiovascular and cerebrovascular events in an independent cohort, years before their occurrence.
More than 90% of atherosclerosis-associated methylation sites overlapped with established cardiovascular risk factor signatures.
Smoking was by far the dominant contributor (up to 90% overlap), followed by inflammation (60%) and metabolic traits (44%).
Methylation at smoking-related CpG sites took decades to normalize to levels similar to those of non-smokers after smoking cessation, suggesting that blood DNA methylation acts as a long-term molecular record of cumulative cardiovascular risk exposure.
Importantly, prior experimental evidence suggests that such exposure-induced methylation changes may causally contribute to persistent risk.
These findings, generated as part of the curATime project biosignATure, raise the intriguing possibility that persistent exposure-driven epigenetic alterations could become future therapeutic targets.
We are grateful for the guidance of JACC EiC Harlan Krumholz throughout the review process, which helped strengthen the paper, and to all contributors and study participants that made this work possible in the first place.”
Title: Blood DNA Methylation Patterns Across Carotid, Coronary, and Peripheral Atherosclerosis: A Comparative Analysis in 2 Prospective Cohorts
Authors: Markus Ingold, Celine Müller, Mykhailo Krolevets, Elif Yapıcı, Steffen Rapp, Alexander K. Schuster, Jonas Tesarz, Isabel Heinrich, Julia Weinmann-Menke, Konstantin Strauch, Karl J. Lackner, Stavros Konstantinides, Wolfram Ruf, Miguel A. Andrade-Navarro, Christof Niehrs, Tommaso Gori, Philipp Lurz, Philipp S. Wild, Vincent ten Cate, Katharina Geschke, Klaus Lieb, Matthias Michal, Irene Schmidtmann
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 30, 2026, 05:18Flora Peyvandi: Molecular and Lab Markers Linked to Bleeding Severity in Factor VII Deficiency
-
Oct 30, 2026, 05:11Rana Al-Hrout: Exploring Approach to Macrocytic Anemia
-
Oct 30, 2026, 04:22Francisco Chacón-Lozsán: Acute Pulmonary Embolism in 2026 – Blood Pressure Is Not the Same as Perfusion
-
Oct 30, 2026, 04:15Samin Mohsenian: Launching the PRO-RBDD-FX Registry for Rare Coagulation Factor X Deficiency
-
Oct 30, 2026, 03:59Emil List Larsen: Identifying SERPINC1 Variants and Limitations of Routine Antithrombin Testing
-
Oct 30, 2026, 02:43D Chandra: Reduce the Apixaban Dose for a Patient with VTE and a Creatinine Clearance of 25?
-
Oct 30, 2026, 02:38Spencer Dorn: Why AI Decision Support Must Integrate Local Clinical Context
-
Oct 30, 2026, 02:33Jens Eschen: Randomized Controlled Trial on Acute Aortic Dissection Anticoagulation Strategies
-
Oct 30, 2026, 02:23Mavis Agnes Kisakye: Landmark Study Paves the Way for Standardized Bleeding Disorder Guidelines in Uganda